4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-19-006617
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SULIMAN SHEHNAAZ · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-01-30 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +20,000 | $48.85 | 2029-01-30 | 20,000 | 20,000 | D |
Loading xslF345X03/doc4.xml…